Page results
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Update about our hospital on Gray's Inn Road
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
Information for patients from overseas visiting UCLH hospitals.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
File results
-
FOI/2022/0080 - Bariatric equipment
-
FOI/2022/0083 - Estates and inrastructure failures
-
FOI/2022/0084 - CA9030 - UCLH-2609 VAT Support and Advice Services contract
-
FOI/2022/0091 - Pancreatic cancer
-
FOI/2022/0093 - Procurement of pre-printed stationery
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0097 - Incidence and treatment of breast cancer
-
FOI/2022/0100 - Physical violence/ verbal assaults committed by patients and/or members of public
-
FOI/2022/0102 - Medical undergraduate education - placements and funding
-
FOI/2022/0103 - Biomedical Science/ Pathology agency usage